A decrease in the molecular weight of hyaluronic acid in synovial fluid from patients with temporomandibular disorders

Journal of Oral Pathology and Medicine

Volumn 33, Issue 4, 2004, Pages 224-229

  Takahashi, Tetsu ^a   Tominaga, Kazuhiro ^a   Takano, Hiroshi ^a   Ariyoshi, Wataru ^a   Habu, Manabu ^a   Fukuda, Jinichi ^a   Maeda, Hiroshi ^b  

^a KYUSHU DENTAL COLLEGE   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

Author keywords

Hyaluronic acid; Internal derangement; Osteoarthritis; Synovial fluid; Synovial fluid analysis; Temporomandibular joint

Indexed keywords

HYALURONIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEASUREMENT; MOLECULAR WEIGHT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDER;

ADOLESCENT; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISLOCATIONS; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSTEOARTHRITIS; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISK; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 1842684737     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0904-2512.2004.00024.x     Document Type: Article

References (39)

1. Laskin D. Etiology and pathogenesis of internal derangement of the temporomandibular joint (current controversies in surgery for internal derangements of the temporomandibular joint). Oral Maxillofac Surg Clin North Am 1994; 6: 217-22.
2. Milam SB, Schmitz JP. Molecular biology of temporomandibular joint disorders, proposed mechanisms of disease. J Oral Maxillofac Surg 1995; 53: 1448-54.
3. Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: a proposed hypothesis. J Oral Maxillofac Surg 1998; 56: 214-23.
4. Aghabeigi B, Haque M, Wasil M, Hodges SJ, Henderson B, Harris M. The role of oxygen free radicals in idiopathic facial pain. Br J Oral Maxillofac Surg 1997; 35: 161-5.
5. Kawai Y, Kubota E, Okabe E. Reactive oxygen species participation in experimentally induced arthritis of the temporomandibular joint in rats. J Dent Res 2000; 79: 1489-95.
6. Shafer DM, Assael L, White LB, White LB, Rossomando EF. Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 1994; 52: 786-91.
7. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 135-41.
8. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami KI. Synovial fluid cytokines and pretenses as markers of temporomandibular joint diseases. J Oral Maxillofac Surg 1998; 56: 192-8.
9. Sandler NA, Buckley MJ, Cillo JE, Braun TW. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangement. J Oral Maxillofac Surg 1998; 56: 534-43.
10. Kubota E, Imamura H, Kubota T, Shibata T, Murakami K. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997; 55: 20-7.
11. Zardeneta G, Milam SB, Lee T, Schmitz JP. Detection and preliminary characterization of matrix metalloproteinase activity in temporomandibular joint lavage fluid. Int J Oral Maxillofac Surg 1998; 27: 397-403.
12. Fraser JRE, Clarris BJ, Baxter E. Patterns of induced variation in the morphology, hyaluronic acid secretion and lysosomal enzyme activity of cultured synovial cells. Ann Rheum Dis 1979; 38: 287-94.
13. Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. Part 1. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967; 10: 357-76.
14. Balazs EA. The physical properties of synovial fluid and the special role of hyaluronic acid. In: Helfet A, ed. Disorders of the Knee. Philadelphia: Lippincott, 1974; 61-74.
15. Dahl LB, Dahl IMS, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985; 44: 817-22.
16. McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 1974; 185: 529-31.
17. Greenwald RA, Moy WW. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum 1980; 23: 455-63.
18. McNeil JD, Wiebkin OW, Betts WH, Cleland LG. Depolymerisation of products of hyaluronic acid after exposure to oxygen-derived free radicals. Ann Rheum Dis 1985; 44: 780-9.
19. Castor CW, Dorstewitz EL. Abnormalities of connective tissue cells cultured from patients with rheumatoid arthritis. part 1. Relative unresponsiveness of rheumatoid synovial cells to hydrocortisone. J Lab Clin Med 1966; 68: 300-13.
20. Vuorio E, Einola S, Hakkarainen S, Penttinen R. Synthesis of underpolymerised hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int 1982; 2: 97-102.
21. Henderson EB, Grootveld M, Farrell A, Smith EC, Thompson PW, Blake DR. A pathological role for damaged hyaluronan in synovitis. Ann Rheum Dis 1991; 50: 196-200.
22. McKee CM, Lowenstein CJ, Horton MR, et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophage through a nuclear factor cob-dependent mechanism. J Boil Chem 1997; 272: 8013-8.
23. Nitzan DW. The process of lubrication impairment and its involvement in temporomandibular joint disc displacement: a theoretical concept. J Oral Maxillofac Surg 2001; 59: 36-45.
24. Nitzan DW, Etsion I. Adhesive force: the underlying cause of the disc anchorage to the fossa and/or eminence in the temporomandibular joint - a new concept. Int J Oral Maxillofac Surg 2002; 31: 94-9.
25. Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Determination of temporomandibular joint fluid concentrations using vitamin B12 as an internal standard. Eur J Oral Sci 1995; 103: 214-8.
26. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantification of chondroitn 4-sulfated and Chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992; 35: 1304-8.
27. Beaty NB, Tew WP, Mello RJ. Relative molecular weight by gel-exclusion high-performance liquid chromatography. Anal Biochem 1985; 147: 387-95.
28. Bjelle A, Andersson T, Granath K. Molecular weight distribution of hyaluronic acid of human synovial fluid in rheumatic diseases. Scand J Rheumatol 1982; 12: 133-8.
29. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 1995; 54: 505-10.
30. Takahashi T, Kondoh T, Kamei K, et al. Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 505-9.
31. Takahashi T, Kondoh T, Ohtani M, Homma H, Fukuda M. Association between arthroscopic diagnosis of temporomandibular joint osteoarthritis and synovial fluid nitric oxide levels. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 129-36.
32. Takahashi T, Homma H, Nagai H, et al. Specific expression of inducible nitric oxide synthase in the synovium of the diseased temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 174-81.
33. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 1999; 38: 602-7.
34. Namiki O, Toyoshima H, Morisaki N. Therapeutic effect on intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol 1982; 20: 501-7.
35. Kopp S, Wennenberg B, Haraldson T, Carlsson GE. The short-term effect of intra-articular injections of sodium hyaluronate and corticosteroid on temporomandibular joint pain and dysfunction. J Oral Maxillofac Surg 1985; 43: 429-35.
36. Sato S, Ohta M, Ohki H, Kawamura H, Motegi K. Effect of lavage with injection of sodium hyaluronate for patients with nonreducing disk displacement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84: 241-4.
37. Peyron JG. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993; 20: 17-27.
38. Adam N, Ghosh P. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid. Inflamm Res 2001; 50: 294-9.
39. Pasquali-Ronchetti I, Quaglino D, Mori G, Bacchelli B, Ghosh P. Hyaluronan-phospholipid interactions. J Struct Biol 1997; 120: 1-10.